Published in
Elsevier, European Journal of Cancer, (155), p. 56-63, 2021
DOI: 10.1016/j.ejca.2021.06.016
Links
Tools
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial
Journal article published in 2021 by
Orazio Caffo 
,
Cinzia Ortega,
Franco Nolè,
Donatello Gasparro,
Claudia Mucciarini,
Michele Aieta,
Vittorina Zagonel,
Roberto Iacovelli,
Ugo De Giorgi,
Gaetano Facchini ,
Antonello Veccia,
Erica Palesandro,
Elena Verri,
Sebastiano Buti ,
Giorgia Razzini
and other authors.
,
Cinzia Ortega,
Franco Nolè,
Donatello Gasparro,
Claudia Mucciarini,
Michele Aieta,
Vittorina Zagonel,
Roberto Iacovelli,
Ugo De Giorgi,
Gaetano Facchini ,
Antonello Veccia,
Erica Palesandro,
Elena Verri,
Sebastiano Buti ,
Giorgia Razzini
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 